Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Höller, Christoph
CA209-587, NCT04204837 / 2016-002811-16: Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin	Recruiting	2	61	Europe	Nivolumab, Nivolumab plus Relatlimab	Salzburger Landeskliniken, Bristol-Myers Squibb	Squamous Cell Carcinoma of the Skin	12/26	12/27